On the Way to Specifically Targeting Minimal Residual Disease?

Breast Cancer Research - United Kingdom
doi 10.1186/bcr2148
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Workshop on Minimal Residual Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Minimal Residual Disease

Leukemia Supplements
2012English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Targeting Melanoma Residual Disease by USP7

Oncotarget
Oncology
2018English

Strategies for Minimal Residual Disease Detection: Current Perspectives

Blood and Lymphatic Cancer: Targets and Therapy
2019English

FLT3 as a Marker of Minimal Residual Disease: Time to Re-Think?

American Journal of Hematology
Hematology
2017English

Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?

Clinical Cancer Research
Cancer ResearchOncology
2015English

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy